Hanlon Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
1,512
-93
| -6% | -$17.3K | 0.2% | 142 |
|
|
2025
Q1 | $336K | Sell |
1,605
-529
| -25% | -$111K | 0.25% | 123 |
|
|
2024
Q4 | $379K | Buy |
2,134
+774
| +57% | +$138K | 0.1% | 130 |
|
|
2024
Q3 | $269K | Buy |
1,360
+180
| +15% | +$35.5K | 0.08% | 141 |
|
|
2024
Q2 | $202K | Buy |
+1,180
| New | +$202K | 0.06% | 156 |
|
|
2023
Q2 | – | Sell |
-7,932
| Closed | -$1.26M | – | 129 |
|
|
2023
Q1 | $1.26M | Sell |
7,932
-58
| -0.7% | -$9.24K | 0.38% | 48 |
|
|
2022
Q4 | $1.29M | Buy |
7,990
+138
| +2% | +$22.3K | 0.44% | 48 |
|
|
2022
Q3 | $1.05M | Buy |
+7,852
| New | +$1.05M | 0.4% | 51 |
|
|
2017
Q2 | – | Sell |
-42,872
| Closed | -$2.79M | – | 27 |
|
|
2017
Q1 | $2.79M | Buy |
+42,872
| New | +$2.79M | 0.35% | 38 |
|
|
2016
Q3 | – | Sell |
-73,216
| Closed | -$4.53M | – | 52 |
|
|
2016
Q2 | $4.53M | Buy |
+73,216
| New | +$4.53M | 0.39% | 80 |
|
|
2016
Q1 | – | Sell |
-64,598
| Closed | -$3.83M | – | 75 |
|
|
2015
Q4 | $3.83M | Buy |
+64,598
| New | +$3.83M | 0.36% | 61 |
|